Fluofarma owns a High Content Screening platform based on laser
scanning cytometry. This innovative platform enables laser scan images,
live microscope or camera viewing analysis on cells or tissues.
► Automated
Platform: Autofocus for automated analysis
► Versatility and flexibility:
- Multiple slide and multiwell plate formats
- Analyze of cell populations, cell
colonies, tissues, tissue arrays
- Laser scan images, live microscope,
camera viewing
- Wide-field images, super-wide-field
sampling, mosaic images
► Fast and efficient:
- Simultaneous acquisition of
multiple-fluorescence & bright field laser-scatter images
- Easily viewed specimens with on-the-fly
galleries, or relocation to individual events
- Precise localization of cells/tissues
events with the automated motorized stage
Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into
a multi-year agreement with Roche.
Read
More